North America Clinical Diagnostics 麻豆原创 2021-2031 by Test , Product , Patient Gender , Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity

Publication ID:

GRM0222030

Publication Date:

February 28, 2022

Pages:

108

Publisher:

Grace 麻豆原创 Data

Countries:

North America [1]

USD 3,100.00

Diseases [2]

Diagnostics [3]

Country Overview (Pharma & Healthcare) [4]

Pharma & Healthcare [5]

Description:

North America clinical diagnostics market is projected to grow by 6.6 % annually in the forecast period and reach $53,670.4 million by 2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, kidney diseases and cancer.

Highlighted with 23 tables and 58 figures, this 108-page report 鈥淣orth America Clinical Diagnostics 麻豆原创 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire North America clinical diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America clinical diagnostics market in every aspect of the classification from perspectives of by Test, Product, Indication, Patient Gender, Age Group, End User, and Country.

Based on Test, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Lipid Panel
鈥� Infectious Disease Testing
鈥� Liver Panel
鈥� Complete Blood Count (CBC)
鈥� Electrolyte Testing
鈥� Renal Panel
鈥� Other Tests

Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Instruments
鈥� Assay Kits & Reagents
鈥� Software & Services

By Indication the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Cardiovascular
鈥� Cancer
鈥� Infectious Disease
鈥� Stroke
鈥� Chronic Lower Respiratory Diseases
鈥� Diabetes
鈥� Other Indications

By Patient Gender the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Male Patients
鈥� Female Patients

By Age Group the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Age 44 and below
鈥� Age 45-64
鈥� Age 65 and over

By End User the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Hospital & Clinics Laboratory
鈥� Diagnostic Laboratory
鈥� Point-of-Care Testing
鈥� Other End Users

Geographically, the following national/local markets are fully investigated:
鈥� U.S.
鈥� Canada
鈥� Mexico

For each key country, detailed analysis, and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Test, Product, and Indication over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
鈥� Abbott Laboratories
鈥� Becton, Dickinson and Company
鈥� BioMerieux SA
鈥� Bio-Rad Laboratories Inc.
鈥� Bio-Reference Laboratories
鈥� Bioscientia Healthcare
鈥� Charles River Laboratories
鈥� Danaher Corporation
鈥� Hoffmann-La Roche AG
鈥� Hologic Inc.
鈥� Qiagen NV
鈥� Siemens Healthcare
鈥� Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of 麻豆原创 Research Methodology 11
1.2.2 麻豆原创 Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 麻豆原创 Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 麻豆原创 Overview and Dynamics 19
2.1 麻豆原创 Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the 麻豆原创 22
2.2 Major Growth Drivers 24
2.3 麻豆原创 Restraints and Challenges 30
2.4 Emerging Opportunities and 麻豆原创 Trends 33
2.5 Porter鈥檚 Fiver Forces Analysis 37
3 Segmentation of North America 麻豆原创 by Test 41
3.1 麻豆原创 Overview by Test 41
3.2 Lipid Panel 43
3.3 Infectious Disease Testing 44
3.4 Liver Panel 45
3.5 Complete Blood Count (CBC) 46
3.6 Electrolyte Testing 47
3.7 Renal Panel 48
3.8 Other Tests 49
4 Segmentation of North America 麻豆原创 by Product 50
4.1 麻豆原创 Overview by Product 50
4.2 Instruments 52
4.3 Assay Kits & Reagents 53
4.4 Software & Services 54
5 Segmentation of North America 麻豆原创 by Indication 55
5.1 麻豆原创 Overview by Indication 55
5.2 Cardiovascular 57
5.3 Cancer 58
5.4 Infectious Disease 59
5.5 Stroke 60
5.6 Chronic Lower Respiratory Diseases 61
5.7 Diabetes 62
5.8 Other Indications 63
6 Segmentation of North America 麻豆原创 by Patient Gender 64
6.1 麻豆原创 Overview by Patient Gender 64
6.2 Male Patients 66
6.3 Female Patients 67
7 Segmentation of North America 麻豆原创 by Age Group 68
7.1 麻豆原创 Overview by Age Group 68
7.2 Age 44 and below 70
7.3 Age 45-64 71
7.4 Age 65 and over 72
8 Segmentation of North America 麻豆原创 by End User 73
8.1 麻豆原创 Overview by End User 73
8.2 Hospital & Clinics Laboratory 75
8.3 Diagnostic Laboratory 76
8.4 Point-of-Care Testing 77
8.5 Other End Users 78
9 North America 麻豆原创 2021-2031 by Country 79
9.1 Overview of North America 麻豆原创 79
9.2 U.S. 82
9.3 Canada 86
9.4 Mexico 88
10 Competitive Landscape 90
10.1 Overview of Key Vendors 90
10.2 New Product Launch, Partnership, Investment, and M&A 93
10.3 Company Profiles 94
Abbott Laboratories 94
Becton, Dickinson and Company 96
BioMerieux SA 97
Bio-Rad Laboratories Inc. 98
Bio-Reference Laboratories 99
Bioscientia Healthcare 100
Charles River Laboratories 101
Danaher Corporation 102
Hoffmann-La Roche AG 103
Hologic Inc. 104
Qiagen NV 105
Siemens Healthcare 106
Thermo Fisher Scientific 107
RELATED REPORTS 108

Companies Mentioned:

Selected Key Players:
鈥� Abbott Laboratories
鈥� Becton, Dickinson and Company
鈥� BioMerieux SA
鈥� Bio-Rad Laboratories Inc.
鈥� Bio-Reference Laboratories
鈥� Bioscientia Healthcare
鈥� Charles River Laboratories
鈥� Danaher Corporation
鈥� Hoffmann-La Roche AG
鈥� Hologic Inc.
鈥� Qiagen NV
鈥� Siemens Healthcare
鈥� Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.